Thermo Fisher Scientific (TMO) Other Non-Current Assets (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Other Non-Current Assets for 18 consecutive years, with $5.6 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 21.69% year-over-year to $5.6 billion; the trailing twelve-month figure through Jun 2026 stood at $5.6 billion (up 21.69% YoY), and the FY2025 full-year result was $5.9 billion, up 30.7% from the prior year.
• Other Non-Current Assets retreated to $5.6 billion in Q2 2026 per TMO's latest filing, from $6.0 billion in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $6.0 billion in Q1 2026 and bottomed at $4.0 billion in Q2 2023.
• Historically, Other Non-Current Assets has averaged $4.6 billion across 5 years, with a median of $4.3 billion in 2022.
• The widest YoY moves for Other Non-Current Assets: up 79.91% in 2022, down 13.64% in 2022.
• Over 5 years, Other Non-Current Assets stood at $4.0 billion in 2022, then decreased by 0.2% to $4.0 billion in 2023, then rose by 12.33% to $4.5 billion in 2024, then soared by 30.7% to $5.9 billion in 2025, then fell by 4.34% to $5.6 billion in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $5.6 billion, $6.0 billion, and $5.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.